These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37062830)

  • 1. Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma.
    Yang J; Jin F; Li H; Shen Y; Shi W; Wang L; Zhong L; Wu G; Wu Q; Li Y
    Cancer Cell Int; 2023 Apr; 23(1):69. PubMed ID: 37062830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
    Chen Z; Cheng G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):666-680. PubMed ID: 37691229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
    Meijing Z; Tianhang L; Biao Y
    Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
    Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
    J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction.
    Zhang Y; Zeng L; Lin D; Chang G; Zeng Y; Xia Y
    Front Endocrinol (Lausanne); 2022; 13():1076521. PubMed ID: 36726460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma.
    Wu Y; Ren L; Tang Y; Zhu Z; Liu S; Jiang Y; Zhang S; Zhuang X; Chen Y
    Aging (Albany NY); 2023 Oct; 15(20):11588-11610. PubMed ID: 37889539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
    Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
    Front Genet; 2022; 13():935056. PubMed ID: 36092903
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
    Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
    Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
    Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
    Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of a Cancer-Testis Antigen-Related Signature to Predict the Prognosis in Stomach Adenocarcinoma.
    Bian G; Cao J; Li W; Huang D; Ding X; Zang X; Ye Y; Li P
    J Cancer; 2024; 15(11):3596-3611. PubMed ID: 38817874
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
    Tu H; Zhang Q; Xue L; Bao J
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma.
    Xiang Z; Cha G; Wang Y; Gao J; Jia J
    Stem Cells Int; 2022; 2022():1888358. PubMed ID: 36238529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.